IMRX Immuneering Corporation

Fundamentals / CIK 0001790340 / USD

Immuneering Corporation reported $182.6M in total assets and a net loss of $66.50M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IMRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$8.72M$4.36M$0-$57.27MFY 2020 Revenue: $2.31MFY 2020 Net Income: -$17.04M2020FY 2021 Revenue: $2.08MFY 2021 Net Income: -$33.54M2021FY 2022 Revenue: $317KFY 2022 Net Income: -$50.51M2022FY 2023 Revenue: $0FY 2023 Net Income: -$53.47M2023FY 2024 Net Income: -$61.04M2024FY 2025 Net Income: -$56.02M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- $0 $317K $2.08M $2.31M
Cost of Revenue -- -- $0 $158K $1.15M $1.28M
Gross Profit -- -- $0 $159K $927K $1.03M
Research & Development $42.05M $47.96M $41.62M $36.27M $26.54M $15.00M
Total Operating Expenses $59.38M $64.07M $58.41M $51.90M $34.81M $18.11M
Operating Income -$59.38M -$64.07M -$58.41M -$51.74M -$33.89M -$17.08M
EBITDA -$59.05M -$63.72M -$58.09M -$51.47M -$33.84M -$17.06M
Interest Income $3.04M $2.59M $3.61M $1.01M $170K $43K
Income Before Tax -- -- -- -$50.51M -$33.84M -$17.04M
Income Tax Expense $0 -- -- -- -$307K --
Net Income -$56.02M -$61.04M -$53.47M -$50.51M -$33.54M -$17.04M
Basic EPS -$1.27 -$2.04 -$1.88 -$1.91 -$2.46 -$3.44
Diluted EPS -$1.27 -$2.04 -$1.88 -$1.91 -$2.46 -$3.44
Basic Shares Outstanding 44.0M 30.0M 28.4M 26.4M 13.6M 5.0M
Diluted Shares Outstanding 44.0M 30.0M 28.4M 26.4M 13.6M 5.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $20.72M $14.00M $10.65M $9.25M $10.87M $10.45M $11.47M $14.86M
Total Operating Expenses $25.79M $19.00M $15.34M $13.75M $15.38M $14.76M $15.48M $18.56M
Operating Income -$25.79M -$19.00M -$15.34M -$13.75M -$15.38M -$14.76M -$15.48M -$18.56M
EBITDA -$25.70M -$18.92M -$15.25M -$13.68M -$15.30M -$14.67M -$15.40M -$18.47M
Interest Income $1.20M $1.08M $1.36M $1.86M $416K $324K $439K $415K
Net Income -$24.19M -$17.27M -$13.46M -$11.58M -$14.96M -$14.43M -$15.05M -$18.05M
Basic EPS -$0.37 -$0.27 -$0.21 -- -$0.38 -$0.40 -$0.42 --
Diluted EPS -$0.37 -$0.27 -$0.21 -- -$0.38 -$0.40 -$0.42 --
Basic Shares Outstanding 64.7M 64.7M 64.7M -- 39.7M 36.0M 35.5M --
Diluted Shares Outstanding 64.7M 64.7M 64.7M -- 39.7M 36.0M 35.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $128.6M $36.14M $59.41M $72.64M $74.89M $37.09M
Short-Term Investments -- $0 $26.26M $32.89M $74.31M --
Cash & Short-Term Investments $128.6M $36.14M $85.67M $105.5M $149.2M $37.09M
Accounts Receivable, Net -- -- $0 $12K $246K $500K
Total Current Assets $176.2M $39.59M $89.08M $108.7M $152.3M $37.73M
Property, Plant & Equipment, Net $938K $1.12M $1.40M $1.37M $807K $64K
Goodwill $6.69M $6.69M $6.69M $6.69M $6.70M --
Intangible Assets $321K $350K $380K $409K $439K --
Long-Term Investments -- -- -- -- $997K --
Other Non-Current Assets $284K $1.30M $1.03M $744K $102K $14K
Total Non-Current Assets $55.74M $13.13M $13.50M $13.62M $14.37M $692K
Total Assets $232.0M $52.71M $102.6M $122.4M $166.7M $38.42M
Accounts Payable $1.54M $1.96M $2.11M $3.15M $1.39M $1.48M
Other Current Liabilities $292K $234K $260K $20K -- --
Total Current Liabilities $10.07M $7.50M $7.85M $8.05M $5.63M $2.26M
Total Non-Current Liabilities $3.43M $3.82M $4.16M $4.46M $5.09M $545K
Total Liabilities $13.50M $11.33M $12.01M $12.52M $10.72M $2.80M
Total Debt (incl. Leases) $3.82M $4.16M $4.46M $4.84M $5.36M $621K
Retained Earnings -$280.3M -$224.3M -$163.3M -$109.8M -$59.27M -$25.74M
Accumulated Other Comp. Income $81K $0 -$778 -$30K -$49K --
Total Stockholders' Equity $218.5M $41.39M $90.58M $109.9M $156.0M -$22.48M
Total Equity $218.5M $41.39M $90.58M $109.9M $156.0M -$22.48M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $58.23M $41.32M $47.32M $128.6M $227.6M $26.36M $35.87M $36.14M
Short-Term Investments -- -- -- -- -- -- $0 $0
Cash & Short-Term Investments $58.23M $41.32M $47.32M $128.6M $227.6M $26.36M $35.87M $36.14M
Total Current Assets $150.7M $158.0M $161.4M $176.2M $229.1M $27.73M $38.21M $39.59M
Property, Plant & Equipment, Net $809K $880K $937K $938K $893K $964K $1.05M $1.12M
Goodwill $6.69M $6.69M $6.69M $6.69M $6.69M $6.69M $6.69M $6.69M
Intangible Assets $299K $307K $314K $321K $328K $336K $343K $350K
Other Non-Current Assets $300K $278K $278K $284K $631K $842K $811K $1.30M
Total Non-Current Assets $31.85M $44.06M $53.40M $55.74M $11.95M $12.33M $12.48M $13.13M
Total Assets $182.6M $202.1M $214.8M $232.0M $241.1M $40.06M $50.68M $52.71M
Accounts Payable $2.76M $3.38M $1.45M $1.54M $1.60M $2.40M $1.31M $1.96M
Other Current Liabilities $89K $214K $44K $292K $80K $210K $57K $234K
Total Current Liabilities $10.79M $8.12M $4.97M $10.07M $9.55M $7.49M $5.11M $7.50M
Total Non-Current Liabilities $3.09M $3.20M $3.32M $3.43M $3.53M $3.63M $3.73M $3.82M
Total Liabilities $13.88M $11.32M $8.29M $13.50M $13.08M $11.12M $8.84M $11.33M
Total Debt (incl. Leases) $3.53M $3.63M $3.73M $3.82M $3.92M $4.00M $4.08M $4.16M
Retained Earnings -$335.2M -$311.1M -$293.8M -$280.3M -$268.7M -$253.8M -$239.3M -$224.3M
Accumulated Other Comp. Income -$549K -$406K -$241K $81K -- -- -- $0
Total Stockholders' Equity $168.7M $190.7M $206.5M $218.5M $228.0M $28.94M $41.84M $41.39M
Total Equity $168.7M $190.7M $206.5M $218.5M $228.0M $28.94M $41.84M $41.39M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$56.02M -$61.04M -$53.47M -$50.51M -$33.54M -$17.04M
Depreciation & Amortization $325K $356K $323K $277K $45K $24K
Stock-Based Compensation $6.31M $6.50M $5.73M $4.06M $1.80M $1.09M
Change in Receivables -- $0 $12K $234K $280K -$290K
Change in Payables -$401K -$112K -$1.11M $1.76M -$130K $1.19M
Operating Cash Flow -$45.34M -$55.00M -$48.97M -$44.10M -$30.85M -$14.62M
Capital Expenditure -$142K -$85K -$343K -$742K -$61K -$53K
Free Cash Flow -$45.49M -$55.08M -$49.31M -$44.84M -$30.91M -$14.67M
Purchases of Investments -$88.60M -$5.41M -$44.66M -$50.10M -$75.63M --
Investing Cash Flow -$88.74M $26.43M $7.30M $41.83M -$75.62M -$53K
Common Stock Issued -- -- $28.20M $0 $120.3M --
Financing Cash Flow $226.6M $5.30M $28.44M $19K $144.3M $37.98M
Net Change in Cash $92.50M -$23.26M -$13.23M -$2.25M $37.80M $23.31M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$24.19M -$17.27M -$13.46M -$11.58M -$14.96M -$14.43M -$15.05M -$18.05M
Depreciation & Amortization $86K $84K $81K $76K $79K $85K $85K $86K
Stock-Based Compensation $2.06M $1.63M $1.64M $1.64M $1.46M $1.52M $1.69M $1.72M
Change in Receivables -- -- -- -- -- -- -- $0
Change in Payables -$619K $1.92M -$90K $73K -$975K $1.19M -$688K $57K
Operating Cash Flow -$16.79M -$16.50M -$18.43M -$9.84M -$11.98M -$9.45M -$14.08M -$14.51M
Capital Expenditure -$15K -$27K -$80K -$124K -$7.3K -$2.1K -$8.9K -$9.4K
Free Cash Flow -$16.80M -$16.53M -$18.51M -$9.96M -$11.98M -$9.45M -$14.09M -$14.52M
Purchases of Investments -$193K -$11.99M -$71.99M -$88.60M $0 $0 $0 --
Investing Cash Flow $33.47M $10.48M -$63.07M -$88.72M -$7.3K -$2.1K -$8.9K $5.49M
Common Stock Issued -- -- -- -- -- $0 $13.68M --
Financing Cash Flow $220K $25K $181K -$358K $213.2M -$62K $13.81M -$41K
Net Change in Cash $16.90M -$6.00M -$81.32M -$98.92M $201.2M -$9.51M -$279K -$9.06M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- 50.1% 44.6% 44.6%
Operating Margin -- -- -- -16325.8% -1629.2% -739.0%
Net Profit Margin -- -- -- -15937.3% -1612.3% -737.2%
Return on Equity (ROE) -25.6% -147.5% -59.0% -46.0% -21.5% --
Return on Assets (ROA) -24.2% -115.8% -52.1% -41.3% -20.1% -44.3%
Current Ratio 17.50x 5.28x 11.35x 13.50x 27.04x 16.73x
Quick Ratio 12.77x 4.82x 10.92x 13.10x 26.53x 16.66x
Debt to Equity 0.02x 0.10x 0.05x 0.04x 0.03x --
Revenue Growth (YoY) -- -- -100.0% -84.8% -10.0% --
Gross Profit Growth (YoY) -- -- -100.0% -82.9% -10.1% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -39.4% -30.0% -26.4% -25.6% -27.4% -214.7% -147.6% -147.5%
Return on Assets (ROA) -36.4% -28.3% -25.3% -24.2% -25.9% -155.1% -121.9% -115.8%
Current Ratio 13.97x 19.47x 32.45x 17.50x 24.00x 3.70x 7.48x 5.28x
Quick Ratio 5.40x 5.09x 9.51x 12.77x 23.84x 3.52x 7.02x 4.82x
Debt to Equity 0.02x 0.02x 0.02x 0.02x 0.02x 0.14x 0.10x 0.10x
Source: SEC EDGAR CompanyFacts (CIK 0001790340) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal